Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma
暂无分享,去创建一个
Alexandre Vignaud | Pierre Brugières | Emmanuel Itti | Michel Meignan | Alain Luciani | Alain Rahmouni | A. Luciani | A. Rahmouni | P. Brugières | C. Haioun | M. Meignan | E. Itti | A. Vignaud | Chieh Lin | K. Belhadj | Corinne Haioun | Karim Belhadj | Chieh Lin | Taoufik El-Gnaoui | Pauline Beaussart | Shih-jui Lin | Eva Evangelista | Shih-jui Lin | E. Evangelista | P. Beaussart | T. Elgnaoui
[1] M. Tomas,et al. 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] S. Takashima,et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. , 2001, Radiology.
[3] K. E. Hunt,et al. Diffuse large B-cell lymphoma. , 2008, Archives of pathology & laboratory medicine.
[4] B. Falini,et al. Diffuse large B‐cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification , 2002, Histopathology.
[5] Sigrid Stroobants,et al. Revised response criteria for malignant lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Modality. APPLICATION OF WHOLE BODY DIFFUSION WEIGHTED MR IMAGING FOR DIAGNOSIS AND STAGING OF MALIGNANT LYMPHOMA , 2008 .
[7] L. Quekel,et al. CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. , 2009, AJR. American journal of roentgenology.
[8] J. Armitage,et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] P. Choyke,et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.
[10] Wilson Fong. Handbook of MRI Pulse Sequences , 2005 .
[11] I. Narabayashi,et al. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience , 2007, Annals of nuclear medicine.
[12] E. Merkle,et al. Extranodal malignant lymphoma: detection with FDG PET versus CT. , 1998, Radiology.
[13] Klemens Scheidhauer,et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] A. Soricelli,et al. Contrast-enhanced harmonic compound US of the spleen to increase staging accuracy in patients with Hodgkin lymphoma: a prospective study. , 2009, Radiology.
[15] T. Takahara,et al. Whole-Body MRI, Including Diffusion-Weighted Imaging, for the Initial Staging of Malignant Lymphoma: Comparison to Computed Tomography , 2009, Investigative radiology.
[16] J Kotzerke,et al. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. , 1997, Radiology.
[17] T. Takahara,et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. , 2004, Radiation medicine.
[18] Pascal Spincemaille,et al. Effective motion‐sensitizing magnetization preparation for black blood magnetic resonance imaging of the heart , 2008, Journal of magnetic resonance imaging : JMRI.
[19] Thomas F Hany,et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT? , 2004, Radiology.
[20] Dow-Mu Koh,et al. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. , 2007, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[21] Peter R. Luijten,et al. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology , 2008, European Radiology.
[22] S. Shiraishi,et al. Diffusion-Weighted Magnetic Resonance Imaging for Diagnosing Malignant Pulmonary Nodules/Masses: Comparison with Positron Emission Tomography , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[23] S. Ng,et al. Primary Cerebral Lymphoma and Glioblastoma Multiforme: Differences in Diffusion Characteristics Evaluated with Diffusion Tensor Imaging , 2008, American Journal of Neuroradiology.
[24] A. Luciani,et al. Liver Cirrhosis : Intravoxel Incoherent Motion MR Imaging — Pilot Study 1 , 2008 .
[25] V. Wedeen,et al. Reduction of eddy‐current‐induced distortion in diffusion MRI using a twice‐refocused spin echo , 2003, Magnetic resonance in medicine.
[26] D. Collins,et al. Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.
[27] Y. Erdi,et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] A. Rahmouni,et al. Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy , 2009, Journal of Nuclear Medicine.
[29] A. Stecco,et al. Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study , 2009, La radiologia medica.
[30] M. Kanematsu,et al. Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect , 2008, European Radiology.
[31] Emmanuel Itti,et al. Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual Analysis , 2007, Journal of Nuclear Medicine.
[32] D. Yeung,et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. , 2007, Radiology.
[33] C. Claussen,et al. Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping—Initial Clinical Experiences in Comparison to PET-CT , 2007, Investigative radiology.
[34] Thomas C Kwee,et al. Imaging in staging of malignant lymphoma: a systematic review. , 2008, Blood.
[35] Frederik De Keyzer,et al. Extracranial applications of diffusion-weighted magnetic resonance imaging , 2007, European Radiology.
[36] Peter R Luijten,et al. Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free‐breathing diffusion‐weighted MR imaging of the liver , 2008, Journal of magnetic resonance imaging : JMRI.
[37] T. Yen,et al. Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[38] K. Chida,et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. , 2009, Radiology.
[39] M. Sumi,et al. Diagnostic ability of apparent diffusion coefficients for lymphomas and carcinomas in the pharynx , 2007, European Radiology.
[40] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[41] Sandra Nuyts,et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. , 2009, Radiology.
[42] Martin Hutchings,et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. , 2006, Blood.
[43] A. Luciani,et al. Quantitative CT analysis for assessing response in lymphoma (Cheson’s criteria) , 2005, Cancer imaging : the official publication of the International Cancer Imaging Society.
[44] H. Honda,et al. Usefulness of the calculated apparent diffusion coefficient value in the differential diagnosis of retroperitoneal masses , 2004, Journal of magnetic resonance imaging : JMRI.